Natriuretic Peptides in Kawasaki Disease: the Myocardial Perspective
Making a diagnosis of Kawasaki disease with certainty may be challenging, especially since the recognition of cases with incomplete diagnostic criteria and its consequences. In order to build the diagnostic case in daily practice, clinicians rely on clinical criteria established over four decades ag...
Main Authors: | Dahdah, Nagib, Fournier, Anne |
---|---|
Format: | Online |
Language: | English |
Published: |
MDPI
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665578/ |
Similar Items
-
Incidence Rate and Epidemiological and Clinical Aspects of Kawasaki Disease in Children of Maghrebi Origin in the Province of Quebec, Canada, Compared to the Country of Origin
by: Gorrab, Arbia Abir, et al.
Published: (2016) -
Imaging-Based Biomarkers: Characterization of Post-Kawasaki Vasculitis in Infants and Hypertension Phenotype in Rat Model
by: Maurice, Roch Listz, et al.
Published: (2012) -
Log-transformed plasma level of brain natriuretic peptide during the acute phase of Kawasaki disease is quantitatively associated with myocardial dysfunction
by: Bang, Sunhee, et al.
Published: (2011) -
Coronary Wall Structural Changes in Patients With Kawasaki Disease: New Insights From Optical Coherence Tomography (OCT)
by: Dionne, Audrey, et al.
Published: (2015) -
Age-adjusted plasma N-terminal pro-brain natriuretic peptide level in Kawasaki disease
by: Jun, Heul, et al.
Published: (2016)